Get started
Author

Chayanit Piyawajanusorn

Data-centric challenges with the application and adoption of artificial intelligence for drug discovery
2024 · Ghita Ghislat, Saiveth Hernandez-Hernandez, et al. · Expert Opinion on Drug Discovery · 55
Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles
2022 · Adeolu Z. Ogunleye, Chayanit Piyawajanusorn, et al. · Advanced Science · 44
PDF
Large-Scale Machine Learning Analysis Reveals DNA Methylation and Gene Expression Response Signatures for Gemcitabine-Treated Pancreatic Cancer
2023 · Adeolu Ogunleye, Chayanit Piyawajanusorn, et al. · Health Data Science · 19
A gentle introduction to understanding preclinical data for cancer pharmaco-omic modeling
2021 · Chayanit Piyawajanusorn, Linh C Nguyen, et al. · Briefings in Bioinformatics · 18
PRIMA-1MET Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells
2019 · CHAYANIT PIYAWAJANUSORN, YINGPINYAPAT KITTIRAT, et al. · Cancer Genomics & Proteomics · 7
PDF
Predicting atezolizumab response in metastatic urothelial carcinoma patients using machine learning on integrated tumour gene expression and clinical data
2025 · Chayanit Piyawajanusorn, Ghita Ghislat, et al. · npj Precision Oncology · 5
PDF
Deconstructing biomarker generalisation failure in cancer anti-pd1 immunotherapy: toward adaptive patient stratification
2025 · Elizabeth Amelia, Chayanit Piyawajanusorn, et al. · Briefings in Bioinformatics
PDF
Cellular senescence protein p16INK4a of cancer-associated fibroblasts (CAFs) as a prognostic indicator for cholangiocarcinoma patients
2018 · Chayanit Piyawajanusorn, Suyanee Thongchot, et al. · Srinagarind Medical Journal-ศรีนครินทร์เวชสาร
Works count: 11
Citation count: 152
H-index: 5
I10-index: 4
Year
Topic
Type